Linked Data API

Filter

These are the filters currently being used to limit the search results. Click on the remove filter icon to remove the filter.

tabling member printed	Henry Smith
min answer › question first answered	2019-06-11T16:43:14.223Z
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of reviewing the way the National Institute for Health and Care Excellence and NHS England evaluate and adopt Advanced Therapy Medicinal Products as technologies with the potential to deliver significant health gains over long periods of time.

Sort by

This list shows the properties that you can sort by. Click on to sort in ascending order and to sort in descending order. The properties that you're currently sorting by are shown at the top of the list. Click on remove this sort to remove a sort and or to reverse the current sort order. Click on the remove all sorting icon to remove all the sorting. Note that sorting can significantly slow down the loading of the page.

View

Choose what information you want to view about each item. There are some pre-defined views, but starred properties are always present no matter what the view. You can star properties by clicking on the icon. The currently starred icons have a icon; clicking on it will unstar the property.

Items per page

Choose how many items to view on each page. The more items you view, the longer the page will take to load.

Show Search Form

Search Results

human indexable

published

registered interest

answer date

exactly:

or between:
and

date

exactly:

or between:
and

date tabled

exactly:

or between:
and

ddp created

exactly:

or between:
and

answering body

question status

answering dept id

answering dept short name

answering dept sort name

ddp modified

hansard heading

house id

identifier

legislature

parliament number

question first answered

question text

session

session number

tabling member constituency

tabling member printed

title

type

uin

version

written parliamentary question type

answer


answer text

creator


label

publisher

tabling member


label

1628301

human indexable

published

registered interest

answer date

18/05/2023

date

16/05/2023

date tabled

16/05/2023

ddp created

16/05/2023 19:21:01

answering body

Department of Health and Social Care

question status

Tabled

answering dept id

answering dept short name

Health and Social Care

answering dept sort name

Health and Social Care

ddp modified

16/05/2023 19:39:18
25/05/2023 13:06:13

hansard heading

Advanced Therapy Medicinal Products

house id

identifier

185240

legislature

25259

parliament number

question first answered

25/05/2023 12:35:12

question text

To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of reviewing the way the National Institute for Health and Care Excellence and NHS England evaluate and adopt Advanced Therapy Medicinal Products as technologies with the potential to deliver significant health gains over long periods of time.

session

2022/23

session number

tabling member constituency

Crawley

tabling member printed

Henry Smith

title

House of Commons Tabled Parliamentary Question 2022/23 185240

type

WrittenParliamentaryQuestion

uin

185240

version

written parliamentary question type

Ordinary

answer

answer

	answer text	<p>The National Institute of Health and Care Excellence (NICE) recently carried out a comprehensive review of its methods and processes for health technology evaluation to ensure that they were appropriate to emerging new technologies such as advanced therapeutic medicinal products (ATMPs). NICE published its updated health technology evaluation manual in January 2022 and has introduced a number of changes that ensure that its appraisal processes are suitable for emerging new medicines, including a broader severity modifier and changes to better respond to uncertainty. There are no plans for a further assessment of NICE’s processes for evaluating ATMPs.</p><p> </p><p>NICE’s methods and processes have been proven to be suitable for ATMPs where companies are willing to price their products in a way that represents value to the taxpayer. NICE has recommended 80% of the ATMPs it has evaluated for use by the National Health Service and they are now available for the treatment of NHS patients, including through the Cancer Drugs Fund and managed access agreements negotiated between the NHS and the manufacturer.</p>

creator

3960

	label	Biography information for Henry Smith

publisher

25259

tabling member

3960

	label	Biography information for Henry Smith